JP2008536844A5 - - Google Patents

Download PDF

Info

Publication number
JP2008536844A5
JP2008536844A5 JP2008506498A JP2008506498A JP2008536844A5 JP 2008536844 A5 JP2008536844 A5 JP 2008536844A5 JP 2008506498 A JP2008506498 A JP 2008506498A JP 2008506498 A JP2008506498 A JP 2008506498A JP 2008536844 A5 JP2008536844 A5 JP 2008536844A5
Authority
JP
Japan
Prior art keywords
group
substituted
aryl
groups
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2008506498A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008536844A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2006/011985 external-priority patent/WO2006113097A2/en
Publication of JP2008536844A publication Critical patent/JP2008536844A/ja
Publication of JP2008536844A5 publication Critical patent/JP2008536844A5/ja
Pending legal-status Critical Current

Links

JP2008506498A 2005-04-15 2006-04-03 ニューロトロフィン類似体を用いた細胞生存促進法 Pending JP2008536844A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US67178505P 2005-04-15 2005-04-15
PCT/US2006/011985 WO2006113097A2 (en) 2005-04-15 2006-04-03 Methods of facilitating cell survival using neurotrophin mimetics

Related Child Applications (2)

Application Number Title Priority Date Filing Date
JP2012220523A Division JP5586673B2 (ja) 2005-04-15 2012-10-02 ニューロトロフィン類似体を用いた細胞生存促進法
JP2012220524A Division JP5645898B2 (ja) 2005-04-15 2012-10-02 ニューロトロフィン類似体を用いた細胞生存促進法

Publications (2)

Publication Number Publication Date
JP2008536844A JP2008536844A (ja) 2008-09-11
JP2008536844A5 true JP2008536844A5 (cg-RX-API-DMAC7.html) 2009-06-18

Family

ID=37115639

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2008506498A Pending JP2008536844A (ja) 2005-04-15 2006-04-03 ニューロトロフィン類似体を用いた細胞生存促進法
JP2012220524A Active JP5645898B2 (ja) 2005-04-15 2012-10-02 ニューロトロフィン類似体を用いた細胞生存促進法
JP2012220523A Active JP5586673B2 (ja) 2005-04-15 2012-10-02 ニューロトロフィン類似体を用いた細胞生存促進法

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2012220524A Active JP5645898B2 (ja) 2005-04-15 2012-10-02 ニューロトロフィン類似体を用いた細胞生存促進法
JP2012220523A Active JP5586673B2 (ja) 2005-04-15 2012-10-02 ニューロトロフィン類似体を用いた細胞生存促進法

Country Status (4)

Country Link
US (5) US7723328B2 (cg-RX-API-DMAC7.html)
EP (3) EP2594318B1 (cg-RX-API-DMAC7.html)
JP (3) JP2008536844A (cg-RX-API-DMAC7.html)
WO (1) WO2006113097A2 (cg-RX-API-DMAC7.html)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110230479A1 (en) * 2005-04-15 2011-09-22 Longo Frank M Neurotrophin mimetics and uses thereof
EP2594318B1 (en) 2005-04-15 2020-06-10 University Of North Carolina At Chapel Hill Methods of facilitating cell survival using neurotrophin mimetics
EP2581440B1 (en) 2005-06-08 2016-03-16 The University of North Carolina At Chapel Hill Methods of facilitating neural cell survival using non-peptide and peptide BDNF neurotrophin mimetics
CN101730531A (zh) * 2007-05-10 2010-06-09 阿瓦隆药品公司 芴、蒽、呫吨、二苯并环庚酮和吖啶的衍生物及其用途
US20110189310A1 (en) * 2008-10-08 2011-08-04 Cornell University Small molecule modulators of prongf uptake
JP2012519703A (ja) * 2009-03-06 2012-08-30 ザ ユニバーシティ オブ ノース カロライナ アット チャペル ヒル ニューロトロフィン・ミメティック及びその使用
US10273219B2 (en) 2009-11-12 2019-04-30 Pharmatrophix, Inc. Crystalline forms of neurotrophin mimetic compounds and their salts
WO2011060262A1 (en) * 2009-11-12 2011-05-19 Pharmatrophix, Inc. Crystalline forms of neurotrophin mimetic compounds and their salts
WO2011066544A2 (en) * 2009-11-30 2011-06-03 Pharmatrophix, Inc. Deuterated compounds useful for treating neurodegenerative diseases
WO2011156632A2 (en) * 2010-06-09 2011-12-15 Georgetown University Compositions and methods of treatment for tumors in the nervous system
CN104995180A (zh) * 2012-09-27 2015-10-21 特罗菲克斯制药股份有限公司 神经营养因子模拟化合物及其盐的结晶形式
US9828330B2 (en) 2013-03-15 2017-11-28 Pharmatrophix, Inc. Non-peptide BDNF neurotrophin mimetics
WO2014143985A1 (en) 2013-03-15 2014-09-18 Pharmatrophix, Inc. Non-peptide bdnf neurotrophin mimetics
GB201414038D0 (en) * 2014-08-07 2014-09-24 Univ Sussex The Alzheimer's disease
EP3412294A1 (en) * 2017-06-08 2018-12-12 Universite De Fribourg Hdac1/2 activator for promoting and/or accelerating myelination and/or remyelination

Family Cites Families (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4743607A (en) * 1987-05-29 1988-05-10 Merrell Dow Pharmaceuticals Inc. Cardiotonic tricyclic imidazolones
JPH04503205A (ja) * 1988-05-02 1992-06-11 ナフッチィ,エヌ,エリック 神経学的活性化合物
US5028622A (en) * 1988-05-06 1991-07-02 Ajinomoto Company, Inc. Administration of amino acids as treatment for neurodegenerative disorders
US5321029A (en) 1988-11-14 1994-06-14 Beecham-Wuelfing Gmbh & Co.K.G. Xanthines
CA2010531A1 (en) 1989-03-06 1990-09-06 Werner Neidhart Amino acid derivatives
DE59205565D1 (de) * 1991-10-07 1996-04-11 Hoechst Ag Carbonsäureester-Schutzgruppen, ein Verfahren zu ihrer Herstellung, ihre Kopplung an eine funktionelle Gruppe sowie ihre Verwendung
US5608067A (en) * 1993-12-09 1997-03-04 Afonso; Adriano 4-substituted pyrazoloquinoline derivatives
GB9402331D0 (en) 1994-02-07 1994-03-30 Univ Mcgill Nerve growth factor structural analogs and their uses
JPH08119922A (ja) * 1994-10-21 1996-05-14 Torii Yakuhin Kk o−ピバロイル−チロシン誘導体
WO1996016980A1 (en) * 1994-11-29 1996-06-06 Novartis Ag Morpholinoethylamide derivatives
JPH1081661A (ja) 1995-10-23 1998-03-31 Sankyo Co Ltd ヒドロキサム酸誘導体
US5958875A (en) 1996-03-29 1999-09-28 The Regents Of The University Of California Synthetic peptides derivatives with nerve growth factor-like neurotrophic activity
WO1997037228A1 (en) * 1996-03-29 1997-10-09 The Trustees Of Boston University Methods for diagnosing and treating alzheimer's disease
AU2645497A (en) 1996-05-06 1997-11-26 Zeneca Limited Thio derivatives of hydroxamic acids
GB9715962D0 (en) 1996-08-23 1997-10-01 Zeneca Ltd Sulfonamides
DK0968206T3 (da) * 1997-02-19 2007-03-26 Berlex Inc N-heterocykliske derivater som NOS-inhibitorer
FR2762315B1 (fr) * 1997-04-22 1999-05-28 Logeais Labor Jacques Derives d'amino-acides inhibiteurs des metalloproteases de la matrice extracellulaire et de la liberation du tnf alpha
WO1998054123A1 (en) * 1997-05-30 1998-12-03 Warner-Lambert Company Substituted peptidylamine calcium channel blockers
AU9064598A (en) * 1998-07-10 2000-02-01 Harald Groger Precusors for pna-monomers
FR2783519B1 (fr) 1998-09-23 2003-01-24 Sod Conseils Rech Applic Nouveaux derives d'amidines, leur preparation, leur application a titre de medicaments et les compositions pharmaceutiques les contenant
AU1379600A (en) * 1998-11-06 2000-05-29 Roche Diagnostics Gmbh Cystine derivatives as therapeutic agents for matrix metalloprotease related diseases
JP2002533338A (ja) * 1998-12-18 2002-10-08 ワーナー−ランバート・カンパニー 非ペプチドnk1レセプターアンタゴニスト
US6583148B1 (en) 1999-04-08 2003-06-24 Krenitsky Pharmaceuticals, Inc. Neurotrophic substituted pyrimidines
US6492380B1 (en) * 1999-05-17 2002-12-10 Queen's University At Kingston Method of inhibiting neurotrophin-receptor binding
US6858577B1 (en) * 1999-06-29 2005-02-22 Ortho-Mcneil Pharmaceutical, Inc. Indole peptidomimetics as thrombin receptor antagonists
DE19939910A1 (de) * 1999-08-23 2001-03-01 Morphochem Ag Neue Verbindungen, die Tryptase-Aktivität hemmen
KR100708247B1 (ko) * 1999-12-08 2007-04-16 데이진 가부시키가이샤 고리형 아민 ccr5 리셉터 길항제
US6881719B2 (en) 2000-01-18 2005-04-19 Mcgill University β-turn peptidomimetic cyclic compounds
AR028606A1 (es) * 2000-05-24 2003-05-14 Smithkline Beecham Corp Nuevos inhibidores de mmp-2/mmp-9
US6699989B1 (en) * 2000-08-28 2004-03-02 B. Vithal Shetty Antiviral and antimicrobial guanidine or biguanidine derivatives
AP2004002952A0 (en) * 2001-07-11 2004-03-31 Elan Pharm Inc N-(3-amino-2-hydroxy-propyl) substituted alkylamide compounds.
US20040248984A1 (en) * 2001-08-29 2004-12-09 Josef Krieglstein Use of $g(b)-adrenoceptor agonists for the treatment of neurodegenerative diseases
CA2466284A1 (en) * 2001-11-08 2003-05-15 Elan Pharmaceuticals, Inc. N, n'-substituted-1,3-diamino-2-hydroxypropane derivatives
UA77526C2 (en) * 2002-06-07 2006-12-15 Sanofi Aventis Substituted derivatives of 1-piperazineacylpiperidine, a method for the preparation thereof and their use in therapy
US7429560B2 (en) 2002-09-25 2008-09-30 Georgia Tech Research Corporation Ketoamide inhibitors in chronic nerve disease
WO2004031145A2 (en) * 2002-10-02 2004-04-15 Bristol-Myers Squibb Company Lactam-containing diaminoalkyl, beta-aminoacids, alpha-aminoacids and derivatives thereof as factor xa inhibitors
US20040186044A1 (en) * 2002-11-06 2004-09-23 Cosgaya Jose Miguel Modulation of myelination by interaction with P75 and TRK receptors
US20040167183A1 (en) * 2003-02-20 2004-08-26 The Procter & Gamble Company Phenethylamino sulfamic acids
GB0304433D0 (en) 2003-02-27 2003-04-02 Xceleron Ltd Improvements relating to chemical libraries
WO2005044810A1 (en) * 2003-10-30 2005-05-19 Janssen Pharmaceutica, N.V. Glyt2 modulators
US20080221157A1 (en) * 2004-07-12 2008-09-11 Istituto Di Ricerche Di Biologia Molecolare P Ange Amide Derivatives as Inhibitors of Histone Deacetylase
EP2594318B1 (en) * 2005-04-15 2020-06-10 University Of North Carolina At Chapel Hill Methods of facilitating cell survival using neurotrophin mimetics
US20110230479A1 (en) * 2005-04-15 2011-09-22 Longo Frank M Neurotrophin mimetics and uses thereof
EP2581440B1 (en) 2005-06-08 2016-03-16 The University of North Carolina At Chapel Hill Methods of facilitating neural cell survival using non-peptide and peptide BDNF neurotrophin mimetics
TW201900217A (zh) * 2005-12-22 2019-01-01 美商海卓勒生物科學公司 用於調節trpa1功能之化合物
WO2008107365A1 (en) 2007-03-02 2008-09-12 Medivir Ab New compounds
JP2012519703A (ja) 2009-03-06 2012-08-30 ザ ユニバーシティ オブ ノース カロライナ アット チャペル ヒル ニューロトロフィン・ミメティック及びその使用

Similar Documents

Publication Publication Date Title
JP2008536844A5 (cg-RX-API-DMAC7.html)
JP2008545793A5 (cg-RX-API-DMAC7.html)
JP2009504748A5 (cg-RX-API-DMAC7.html)
EP2371811A3 (en) Azetidinecarboxylic acid derivative and medicinal use thereof
EP1857457A3 (en) Benzimidazole derivative and its use as AII receptor antagonist
JP2013526544A5 (cg-RX-API-DMAC7.html)
JP2006513268A5 (ja) アンタゴニスト活性を有するベンゾアゾリルピペラジン誘導体
JP2011504903A5 (cg-RX-API-DMAC7.html)
AR061584A1 (es) Uso de 2-aminotetralinas sustituidas para la fabricacion de un medicamento para la prevencion, alivio y/o tratamiento de diversos tipos de dolor
JP2012530779A5 (cg-RX-API-DMAC7.html)
JP2012506872A5 (cg-RX-API-DMAC7.html)
EP3110792B1 (en) Aminocarbonylcarbamate compounds
JP2013519653A5 (cg-RX-API-DMAC7.html)
JP2013513588A5 (cg-RX-API-DMAC7.html)
JP2010530002A5 (cg-RX-API-DMAC7.html)
JP2012525437A5 (cg-RX-API-DMAC7.html)
JP2007502832A5 (cg-RX-API-DMAC7.html)
RU2017115726A (ru) Ингибиторы лизин-специфичного гингипаина
JP2009541493A5 (cg-RX-API-DMAC7.html)
WO2019025588A1 (en) METHODS OF TREATING ALTERATIONS IN BEHAVIOR
JP2015502371A5 (cg-RX-API-DMAC7.html)
JP5951500B2 (ja) 新しいアミノテトラリン誘導体
RU2012150501A (ru) Противораковые стероидные лактоны, ненасыщенные в положении 7(8)
JP2010514734A5 (cg-RX-API-DMAC7.html)
JP2016537432A5 (cg-RX-API-DMAC7.html)